| |
Angiographic Predictors of 6-Month Patency of Bypass Grafts Implanted to the Right Coronary Artery a Prospective Randomized Comparison of Gastroepiploic Artery and Saphenous Vein Grafts
J Am Coll Cardiol (2008) 51;120-5
D. Glineur, et al. |
| |
Saphenous Vein Graft Stenting and Major Adverse Cardiac Events: A Predictive Model Derived from a Pooled Analysis of 3958 Patients
Circulation (2008) 117;790-7
A. Coolong, et al. |
| |
Percutaneous Intervention on the Saphenous Vein Bypass Grafts--Long-Term Outcomes
Catheter Cardiovasc Interv (2008) 71;58-61
D. Bansal, et al. |
| |
Long-Term Outcomes with Drug-Eluting Stents Versus Bare Metal Stents in the Treatment of Saphenous Vein Graft Disease (Results from the Registro Regionale Angioplastiche Emilia-Romagna Registry)
Am J Cardiol (2008) 101;947-52
L. Vignali, et al. |
| |
Short- and Long-Term Outcomes after Stent-Assisted Percutaneous Treatment of Saphenous Vein Grafts in the Drug-Eluting Stent Era
Am J Cardiol (2008) 101;63-8
T. Pucelikova, et al. |
| |
Visualization of the Cardiac Venous System Using Cardiac Magnetic Resonance
Am J Cardiol (2008) 101;407-12
A. Chiribiri, et al. |
| |
Increased Late Mortality after Sirolimus-Eluting Stents Versus Bare-Metal Stents in Diseased Saphenous Vein Grafts: Results from the Randomized Delayed Rrisc Trial
J Am Coll Cardiol (2007) 50;261-7
P. Vermeersch, et al. |
| |
Prediction of Distal Embolization During Percutaneous Coronary Intervention in Saphenous Vein Grafts
Am J Cardiol (2007) 99;603-6
W. J. van Gaal, et al. |
| |
A Prospective Study of Trans Fatty Acids in Erythrocytes and Risk of Coronary Heart Disease
Circulation (2007) 115;1858-65
Q. Sun, et al. |
| |
Short- and Long-Term Outcomes after Stent-Assisted Percutaneous Treatment of Saphenous Vein Grafts in the Drug-Eluting Stent Era
Am J Cardiol (2008) 101;63-8
T. Pucelikova, et al. |
| |
Utilization of Distal Embolic Protection in Saphenous Vein Graft Interventions (an Analysis of 19,546 Patients in the American College of Cardiology-National Cardiovascular Data Registry)
Am J Cardiol (2007) 100;1114-8
S. K. Mehta, et al. |
| |
The Proximal Trial: Proximal Protection During Saphenous Vein Graft Intervention Using the Proxis Embolic Protection System: A Randomized, Prospective, Multicenter Clinical Trial
J Am Coll Cardiol (2007) 50;1442-9
L. Mauri, et al. |
| |
Thrombus Predicts Ischemic Complications During Percutaneous Coronary Intervention in Saphenous Vein Grafts: Results from Target (Do Tirofiban and Reopro Give Similar Efficacy Trial?)
Catheter Cardiovasc Interv (2007) 69;623-9
A. Kalyanasundaram, et al. |
| |
Peri-Stent Reference Segment Plaque Burden Is Associated with Disease Progression in Saphenous Vein Grafts (a Serial Intravascular Ultrasound Assessment)
Am J Cardiol (2007) 100;1233-8
Y. J. Hong, et al. |
| |
Implantation of Paclitaxel-Eluting Stents in Saphenous Vein Grafts: Clinical and Angiographic Follow-up Results from a Multicentre Study
Heart (2007) 93;331-4
R. Hoffmann, et al. |
| |
Safety and Efficacy of the Filterwire Ez in Acute St-Segment Elevation Myocardial Infarction
Am J Cardiol (2007) 99;911-5
V. Guetta, et al. |
| |
Recombinant Nematode Anticoagulant Protein C2 in Patients with Non-St-Segment Elevation Acute Coronary Syndrome: The Anthem-Timi-32 Trial
J Am Coll Cardiol (2007) 49;2398-407
R. P. Giugliano, et al. |
| |
Impact of Patient and Target-Vessel Characteristics on Arterial and Venous Bypass Graft Patency: Insight from a Randomized Trial
Circulation (2007) 115;684-91
N. D. Desai, et al. |
| |
| |
| |
 |